SEARCH

SEARCH BY CITATION

References

  • Akiyama K, Hora M, Tatemichi S, Masuda N, Nakamura S, Yamagishi R et al. (1999). KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model. J Pharmacol Exp Ther 291: 8191.
  • Bell CM, Hatch WV, Fischer HD, Cernat G, Paterson JM, Gruneir A et al. (2009). Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery. JAMA 301: 19911996.
  • Chang DF, Campbell JR (2005). Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 31: 664673.
  • Chapple CR, Andersson KE (2002). Tamsulosin: an overview. World J Urol 19: 397404.
  • Chapple CR, Baert L, Thind P, Höfner K, Khoe GS, Spångberg A (1997). Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group. Eur Urol 32: 462470.
  • Chueh SC, Chern JW, Choong CM, Guh JH, Teng CM (2002). Characterization of some novel alpha 1-adrenoceptor antagonists in human hyperplastic prostate. Eur J Pharmacol 445: 125131.
  • Craig AG, Norberg T, Griffin D, Hoeger C, Akhtar M, Schmidt K et al. (1999). Contulakin-G, an O-glycosylated invertebrate neurotensin. J Biol Chem 274: 1375213759.
  • Davenport K, Timoney AG, Keeley FX Jr (2007). Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol Res 35: 207213.
  • Dünnhaupt S, Barthelmes J, Iqbal J, Perera G, Thurner CC, Friedl H et al. (2012). In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan. J Control Release 160: 477485.
  • Dykstra LA, Bertalmio AJ, Woods JH (1988). Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2 analysis. Psychopharmacol Ser 4: 107121.
  • Gray K, Short J, Ventura S (2008). The alpha1A-adrenoceptor gene is required for the alpha1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate. Br J Pharmacol 155: 103109.
  • Hatano A, Tang R, Walden PD, Lepor H (1996). The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate. Eur J Pharmacol 313: 135143.
  • Kenakin T (2009). A Pharmacology Primer: Theory, Application and Methods. Elsevier Academic Press: London, pp. 101127.
  • Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 15771579.
  • Koshimizu TA, Tanoue A, Hirasawa A, Yamauchi J, Tsujimoto G (2003). Recent advances in alpha1-adrenoceptor pharmacology. Pharmacol Ther 98: 235244.
  • Lluel P, Guilloteau V, Palea S (2008). Alfuzosin reverses bladder overactivity induced by cyclophosphamide in conscious rats. J Urol 79 (4 Suppl.): 371.
  • McGrath J, Drummond G, Kilkenny C, Wainwright C (2010). Guidelines for reportingexperiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 15731576.
  • Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G (2009). Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. J Urol 181: 26342640.
  • Muramatsu I, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman AS, Tanaka T et al. (2008). Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout. Br J Pharmacol 155: 12241234.
  • Negus SS, Burke TF, Medzihradsky F, Woods JH (1993). Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267: 896903.
  • Nielsen DB, Dykert J, Rivier JE, McIntosh JM (1994). Isolation of Lys-conopressin-G from the venom of the worm-hunting snail, Conus imperialis. Toxicon 32: 845848.
  • Noble AJ, Chess-Williams R, Couldwell C, Furukawa K, Uchyiuma T, Korstanje C et al. (1997). The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes. Br J Pharmacol 120: 231238.
  • Palea S, Barras M, Deplanne V, Vallancien G (2000). Antagonistic effects of alfuzosin on concentration-response curves to phenylephrine and noradrenaline in human prostatic adenoma. Neurourol Urodyn 19: 431433.
  • Porpiglia F, Vaccino D, Billia M, Renard J, Cracco C, Ghignone G et al. (2006). Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur Urol 50: 339344.
  • Pulito VL, Li X, Varga SS, Mulcahy LS, Clark KS, Halbert SA et al. (2000). An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists. J Pharmacol Exp Ther 294: 224229.
  • Quinton L, Girard E, Maiga A, Rekik M, Lluel P, Masuyer G et al. (2010). Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor. Br J Pharmacol 159: 316325.
  • Sato S, Ohtake A, Matsushima H, Saitoh C, Usuda S, Miyata K (2001). Pharmacological effect of tamsulosin in relation to dog plasma and tissue concentrations: prostatic and urethral retention possibly contributes to uroselectivity of tamsulosin. J Pharmacol Exp Ther 296: 697703.
  • Servent D, Fruchart-Gaillard C (2009). Muscarinic toxins: tool for the study of the pharmacological and functional properties of muscarinic receptors. J Neurochem 109: 11931202.
  • Sharpe IA, Gehrmann J, Loughnan ML, Thomas L, Adams DA, Atkins A et al. (2001). Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter. Nat Neurosci 4: 902907.
  • Trevisani M, Campi B, Gatti R, André E, Materazzi S, Nicoletti P et al. (2007). The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract. Eur Urol 52: 901908.
  • Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H (2005). The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 173: 20102012.